MILITO, CINZIA
 Distribuzione geografica
Continente #
AS - Asia 1.344
NA - Nord America 860
EU - Europa 828
SA - Sud America 127
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.211
Nazione #
US - Stati Uniti d'America 816
SG - Singapore 573
RU - Federazione Russa 438
CN - Cina 277
VN - Vietnam 251
IT - Italia 129
HK - Hong Kong 113
BR - Brasile 102
DE - Germania 74
FR - Francia 50
GB - Regno Unito 31
NL - Olanda 31
JP - Giappone 26
CA - Canada 23
CI - Costa d'Avorio 22
KR - Corea 20
FI - Finlandia 19
IN - India 17
MX - Messico 16
AR - Argentina 11
PH - Filippine 11
BD - Bangladesh 10
PL - Polonia 10
ZA - Sudafrica 10
ES - Italia 8
IQ - Iraq 7
SE - Svezia 6
TR - Turchia 6
TW - Taiwan 6
AT - Austria 5
BE - Belgio 5
EC - Ecuador 5
ID - Indonesia 5
IE - Irlanda 5
TH - Thailandia 5
CO - Colombia 4
MA - Marocco 4
EG - Egitto 3
JO - Giordania 3
LT - Lituania 3
SN - Senegal 3
UA - Ucraina 3
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
GY - Guiana 2
KE - Kenya 2
NP - Nepal 2
TZ - Tanzania 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SV - El Salvador 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.211
Città #
Singapore 312
San Jose 126
Ashburn 110
Hong Kong 108
Hefei 101
Moscow 101
Beijing 64
Ho Chi Minh City 62
Hanoi 57
Santa Clara 57
Los Angeles 48
Chandler 37
The Dalles 34
Munich 27
Tokyo 25
Lauterbourg 24
Amsterdam 21
Naples 19
Düsseldorf 17
New York 17
Seoul 17
Frankfurt am Main 13
Orem 13
Da Nang 12
Haiphong 12
Turku 12
São Paulo 11
Buffalo 10
Rome 10
Chicago 9
Montreal 9
Warsaw 9
Boston 8
Dong Ket 8
London 8
Mexico City 8
Redondo Beach 8
Dallas 7
Falkenstein 7
Millbury 7
Washington 7
Atlanta 6
Biên Hòa 6
Brooklyn 6
Denver 6
Des Moines 6
Stockholm 6
Toronto 6
Brussels 5
Dublin 5
Houston 5
Lawrence 5
Milan 5
Nanjing 5
Ottawa 5
Phoenix 5
Poplar 5
Brasília 4
Council Bluffs 4
Dhaka 4
Helsinki 4
Hải Dương 4
Johannesburg 4
Paris 4
Rochdale 4
Salvador 4
San Francisco 4
Seattle 4
Thái Nguyên 4
Tianjin 4
Vĩnh Long 4
Baghdad 3
Cairo 3
Dakar 3
Fortaleza 3
Guayaquil 3
Ha Long 3
Lappeenranta 3
Manchester 3
Napoli 3
New Delhi 3
Nuremberg 3
Philadelphia 3
Piscataway 3
Princeton 3
Rio de Janeiro 3
Roubaix 3
Somma Vesuviana 3
Thái Bình 3
Turin 3
Tân Tiến 3
Điện Bàn 3
Amman 2
Bitonto 2
Bologna 2
Bắc Ninh 2
Can Tho 2
Carney 2
Casablanca 2
Chongqing 2
Totale 1.794
Nome #
A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes 243
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 163
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 149
Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET) 148
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 148
Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network 147
B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies 144
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers 138
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 133
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best 129
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study 128
Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42] 127
Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy 125
Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies 123
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia 122
Rapid infusions of human normal immunoglobulin 50 g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia 122
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study 122
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study 121
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic 121
Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job’s syndrome 119
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 116
Correction to: Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group 106
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 98
Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era 82
The Usefulness of Scintigraphic Studies in the Assessment of Asymptomatic Bowel Disease in Patients with Primary Antibody Diseases 79
Totale 3.253
Categoria #
all - tutte 9.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/202247 0 0 1 0 0 0 0 1 4 3 18 20
2022/2023138 9 13 3 1 11 8 6 11 45 10 16 5
2023/2024170 9 20 24 16 11 16 3 29 8 3 19 12
2024/2025997 37 40 7 10 61 43 68 81 67 119 363 101
2025/20261.853 208 160 214 205 275 108 248 79 201 119 36 0
Totale 3.253